• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对口腔生物膜的CafA靶向BAR包封纳米颗粒的评估

Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.

作者信息

Desai Hetal, Mahmoud Mohamed Y, Tan Jinlian, Minooei Farnaz, Demuth Donald R, Steinbach-Rankins Jill M

机构信息

Department of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY 40202, USA.

Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY 40202, USA.

出版信息

Pharmaceutics. 2020 Sep 1;12(9):835. doi: 10.3390/pharmaceutics12090835.

DOI:10.3390/pharmaceutics12090835
PMID:32882864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7557775/
Abstract

adherence to is a crucial initial event that facilitates the colonization of , a key pathogen in periodontal disease. As such, blocking these early interactions may present a potential avenue to limit colonization. Nanoparticles encapsulating a synthetic peptide BAR (BAR-encapsulated NPs) inhibit / biofilm formation 1.8-fold more potently relative to free BAR. However, BAR-encapsulated NPs, like many orally delivered formulations, may benefit from a strategy that improves their retention in an open flow environment. Here, we sought to enhance the efficacy of BAR-encapsulated NPs by modifying their surfaces with coaggregation factor A (CafA), a fimbrial protein expressed by the early colonizer, . We demonstrate that the targeting moiety, CafA, enhances NP binding and exhibits specificity of adherence to , relative to other oral bacterial species. Furthermore, CafA-modified NPs release inhibitory concentrations of BAR for 12 h, a time frame relevant to oral dosage form delivery. Lastly, CafA-modified NPs potently inhibit / biofilm formation for up to 12 h and are non-toxic at therapeutically-relevant concentrations. These results suggest that CafA-modified NPs represent a novel and efficacious delivery vehicle for localized, targeted delivery of BAR to preferred niches.

摘要

黏附于牙龈卟啉单胞菌是促进其定植的关键初始事件,牙龈卟啉单胞菌是牙周病的关键病原体。因此,阻断这些早期相互作用可能是限制牙龈卟啉单胞菌定植的潜在途径。包裹合成肽BAR的纳米颗粒(BAR包裹的纳米颗粒)抑制牙龈卟啉单胞菌生物膜形成的能力比游离BAR强1.8倍。然而,与许多口服制剂一样,BAR包裹的纳米颗粒可能受益于一种能提高其在开放流动环境中滞留率的策略。在这里,我们试图通过用共聚凝集因子A(CafA)修饰BAR包裹的纳米颗粒表面来提高其功效,CafA是早期定植菌血链球菌表达的一种菌毛蛋白。我们证明,与其他口腔细菌种类相比,靶向部分CafA增强了纳米颗粒的结合,并表现出对血链球菌黏附的特异性。此外,CafA修饰的纳米颗粒在12小时内释放出抑制浓度的BAR,这与口服剂型给药的时间框架相关。最后,CafA修饰的纳米颗粒在长达12小时内有效抑制牙龈卟啉单胞菌生物膜形成,并且在治疗相关浓度下无毒。这些结果表明,CafA修饰的纳米颗粒是一种新型且有效的递送载体,可将BAR局部靶向递送至血链球菌的优选生态位。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/a900a5233d65/pharmaceutics-12-00835-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/c28aa76741f6/pharmaceutics-12-00835-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/ccc7722cbb71/pharmaceutics-12-00835-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/7933316b0ab3/pharmaceutics-12-00835-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/198f292c7777/pharmaceutics-12-00835-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/397eabee31fd/pharmaceutics-12-00835-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/6949285648da/pharmaceutics-12-00835-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/a900a5233d65/pharmaceutics-12-00835-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/c28aa76741f6/pharmaceutics-12-00835-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/ccc7722cbb71/pharmaceutics-12-00835-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/7933316b0ab3/pharmaceutics-12-00835-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/198f292c7777/pharmaceutics-12-00835-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/397eabee31fd/pharmaceutics-12-00835-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/6949285648da/pharmaceutics-12-00835-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ca3/7557775/a900a5233d65/pharmaceutics-12-00835-g007.jpg

相似文献

1
Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.针对口腔生物膜的CafA靶向BAR包封纳米颗粒的评估
Pharmaceutics. 2020 Sep 1;12(9):835. doi: 10.3390/pharmaceutics12090835.
2
Peptide-modified nanoparticles inhibit formation of biofilms with .肽修饰的纳米颗粒抑制生物膜的形成。
Int J Nanomedicine. 2017 Jun 22;12:4553-4562. doi: 10.2147/IJN.S139178. eCollection 2017.
3
BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.包被纳米颗粒抑制和破坏牙龈卟啉单胞菌-戈登链球菌生物膜。
J Nanobiotechnology. 2018 Sep 15;16(1):69. doi: 10.1186/s12951-018-0396-4.
4
Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.在牙周炎的小鼠模型中,评估肽修饰的 PLGA 纳米颗粒对口腔生物膜的功能。
J Control Release. 2019 Mar 10;297:3-13. doi: 10.1016/j.jconrel.2019.01.036. Epub 2019 Jan 25.
5
Rapid Release Polymeric Fibers for Inhibition of Adherence to .用于抑制粘附的快速释放聚合物纤维
Front Chem. 2020 Jan 21;7:926. doi: 10.3389/fchem.2019.00926. eCollection 2019.
6
Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation.肽介导抑制牙龈卟啉单胞菌生物膜形成的结构表征
Infect Immun. 2006 Oct;74(10):5756-62. doi: 10.1128/IAI.00813-06.
7
Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii.牙龈卟啉单胞菌黏附至戈登链球菌肽抑制剂的结构剖析与体内有效性
Infect Immun. 2011 Jan;79(1):67-74. doi: 10.1128/IAI.00361-10. Epub 2010 Nov 1.
8
Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis.选择性取代氨基酸可限制蛋白水解切割并提高针对牙周病原体牙龈卟啉单胞菌的抗生物膜肽的生物活性。
Peptides. 2010 Dec;31(12):2173-8. doi: 10.1016/j.peptides.2010.08.014. Epub 2010 Aug 26.
9
Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates.戈登氏链球菌SspB蛋白在牙龈卟啉单胞菌在链球菌底物上生物膜形成中的作用。
Microbiology (Reading). 2002 Jun;148(Pt 6):1627-1636. doi: 10.1099/00221287-148-6-1627.
10
Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation.烟草烟雾增强牙龈卟啉单胞菌-戈登链球菌生物膜的形成。
PLoS One. 2011;6(11):e27386. doi: 10.1371/journal.pone.0027386. Epub 2011 Nov 14.

引用本文的文献

1
Nanoparticles as Strategies for Modulating the Host's Response in Periodontitis Treatment.纳米颗粒作为调节宿主对牙周炎治疗反应的策略。
Nanomaterials (Basel). 2025 Mar 21;15(7):476. doi: 10.3390/nano15070476.
2
Nanoparticles in Periodontitis Therapy: A Review of the Current Situation.牙周炎治疗中的纳米粒子:现状综述。
Int J Nanomedicine. 2024 Jul 9;19:6857-6893. doi: 10.2147/IJN.S465089. eCollection 2024.
3
Bacteria autoaggregation: how and why bacteria stick together.细菌自动聚集:细菌为何及如何黏附在一起。

本文引用的文献

1
Application of computational fluid dynamics models for the evaluation of salivary flow patterns and related bacterial accumulation around orthodontic brackets.应用计算流体动力学模型评估正畸托槽周围的唾液流动模式及相关细菌积聚。
Orthod Craniofac Res. 2020 Aug;23(3):291-299. doi: 10.1111/ocr.12369. Epub 2020 Feb 20.
2
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies.用癌症靶向抗体功能化纳米颗粒:策略比较。
J Control Release. 2020 Apr 10;320:180-200. doi: 10.1016/j.jconrel.2020.01.035. Epub 2020 Jan 21.
3
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems.
Biochem Soc Trans. 2021 Jun 30;49(3):1147-1157. doi: 10.1042/BST20200718.
用于粘膜粘附给药系统的壳聚糖及其衍生物
Polymers (Basel). 2018 Mar 5;10(3):267. doi: 10.3390/polym10030267.
4
Functional assessment of peptide-modified PLGA nanoparticles against oral biofilms in a murine model of periodontitis.在牙周炎的小鼠模型中,评估肽修饰的 PLGA 纳米颗粒对口腔生物膜的功能。
J Control Release. 2019 Mar 10;297:3-13. doi: 10.1016/j.jconrel.2019.01.036. Epub 2019 Jan 25.
5
Peptide ligand-mediated targeted drug delivery of nanomedicines.肽配体介导的纳米药物靶向药物递送。
Biomater Sci. 2019 Jan 29;7(2):461-471. doi: 10.1039/c8bm01340c.
6
BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.包被纳米颗粒抑制和破坏牙龈卟啉单胞菌-戈登链球菌生物膜。
J Nanobiotechnology. 2018 Sep 15;16(1):69. doi: 10.1186/s12951-018-0396-4.
7
Nanoparticle localization in blood vessels: dependence on fluid shear stress, flow disturbances, and flow-induced changes in endothelial physiology.纳米颗粒在血管中的定位:依赖于流体切应力、流动干扰以及血流引起的内皮生理变化。
Nanoscale. 2018 Aug 16;10(32):15249-15261. doi: 10.1039/c8nr03440k.
8
Progress and challenges towards targeted delivery of cancer therapeutics.癌症治疗靶向递药的进展与挑战。
Nat Commun. 2018 Apr 12;9(1):1410. doi: 10.1038/s41467-018-03705-y.
9
Peptide-modified nanoparticles inhibit formation of biofilms with .肽修饰的纳米颗粒抑制生物膜的形成。
Int J Nanomedicine. 2017 Jun 22;12:4553-4562. doi: 10.2147/IJN.S139178. eCollection 2017.
10
New approaches to combat biofilms.对抗生物膜的新方法。
J Oral Microbiol. 2017 Mar 15;9(1):1300366. doi: 10.1080/20002297.2017.1300366. eCollection 2017.